The renin-angiotensin system

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 135-144

  Lai, Kar Neng ^a   Leung, Joseph C K ^a   Tang, Sydney C W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR;

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PODOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; PODOCYTES; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM;

EID: 79959219641     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000325649     Document Type: Article

References (32)

1. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994;93:2431-2437. (Pubitemid 24177156)
2. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM: Gene expression of the reninangiotensin system in human kidney. J Hypertens 1998;16:91-102. (Pubitemid 28069825)
3. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ: In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. A hypothesis for the intrarenal renin angiotensin system. J Clin Invest 1990;85:417-423. (Pubitemid 20070047)
4. Terada Y, Tomita K, Nonoguchi H, Marumo F: PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 1993;43:1251-1259. (Pubitemid 23161411)
5. Kobori H, Harrison-Bernard LM, Navar LG: Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 2001;12:431-439. (Pubitemid 32180011)
6. Henrich WL, McAllister EA, Eskue A, Miller T, Moe OW: Renin regulation in cultured proximal tubular cells. Hypertension 1996; 27:1337-1340. (Pubitemid 26165640)
7. Kobori H, Nangaku M, Navar LG, Nishiyama A: The intrarenal renin-angiotensin system: From physiology to pathobiology of hypertension and kidney disease. Pharmacol Rev 2007;59:251-287. (Pubitemid 47481436)
8. Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B: Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin Am J Soc Nephrol 2006;1:940-951.
9. Ischihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H: The (pro)renin receptor and the kidney. Semin Nephrol 2007;27: 524-528. (Pubitemid 47374903)
10. Lai KN, Chan LY, Tang SC, Tsang AW, Li FF, Lam MF, Lui SL, Leung JC: Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int 2004;66:1403-1416. (Pubitemid 39298372)
11. Wang L, Flannery PJ, Spurney RF: Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 2003; 142:313-321. (Pubitemid 37487401)
12. Chan LY, Leung JC, Tang SC, Choy BY, Lai KN: Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol 2005;16: 2306-2317. (Pubitemid 41725048)
13. Miyata N, Park F, Li XF, Cowley AW Jr: Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol 1999;277:F437-F446. (Pubitemid 29459656)
14. Paul M, Mehr AP, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747-803. (Pubitemid 44033382)
15. Huang J, Siragy HM: Glucose promotes the production of interleukin-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression. Endocrinology 2009;150:5557-5565.
16. Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int 2000;(suppl 77):S93-S98.
17. Zhang SL, To C, Chen X, Filep JG, Tang SS, Ingelfinger JR, Carriere S, Chan JS: Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells. Exp Nephrol 2001;9: 109-117. (Pubitemid 32041488)
18. Colucci JA, Arita DY, Cunha TS, Di Marco GS, Vio CP, Pacheco-Solva A, Casarini DE: Renin-angiotensin system may trigger kidney damage in NOD mice. J Renin Angiotensin Aldosterone Syst 2010, Epub ahead of print.
19. Okazaki Y, Yamasaki Y, Uchida HA, Okamoto K, Satoh M, Maruyama K, Maeshima Y, Sugiyama H, Sugaya T, Kashihara N, Makino H: Enhanced TGFbeta/ Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clin Exp Nephrol 2007;11:77-87. (Pubitemid 46474968)
20. Deb DK, Chen Y, Zhang Z, Zhang Y, Szeto FL, Wong KE, Kong J, Li YC: 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-kappaB pathway. Am J Physiol Renal Physiol 2009; 296:F1212-F1218.
21. Velez JCQ, Bland AM, Arthur JM, Raymond JR, Janech MG: Characterization of reninangiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007;293:F398-F407. (Pubitemid 47345041)
22. Dilauro M, Burns KD: Angiotensin-(1-7) and its effects in the kidney. Sci World J 2009;9:522-535.
23. Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM: Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetic and kidney disease. Kidney Int 2008;74:1610-1616.
24. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D: Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: Implication for albuminuria in diabetes. J Am Soc Nephrol 2006;17:3067-3075. (Pubitemid 44707767)
25. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, Pichler R, Griffin S, Couser WG, Shankland SJ: Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004;65:30-39. (Pubitemid 38037489)
26. Durvasula RV, Shankland SJ: Activation of a local renin angiotensin system in podocytes by glucose. Am J Physiol Renal Physiol 2008; 294:F830-F839.
27. Yoo TH, Li JJ, Kim JJ, Jung DS, Kwak SJ, Ryu DR, Choi HY, Kim JS, Kim HJ, Han SH, Lee JE, Han DS, Kang SW: Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int 2007;71:1019-1027. (Pubitemid 46741993)
28. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, Singhal PC: Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002;283:F173-F180. (Pubitemid 34680484)
29. Ziyadeh FN, Wolf G: Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008;4:39-45. (Pubitemid 351210971)
30. Ruster C, Bondeva T, Franke S, Tanaka N, Yamamoto H, Wolf G: Angiotensin II upregulates RAGE expression on podocytes: Role of AT2 receptors. Am J Nephrol 2009;29: 538-550.
31. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, Camussi G: Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003;52:1023-1030. (Pubitemid 36384273)
32. Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G: Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 2008;3: 1511-1525.